Universitas Medica is a prominent journal dedicated to advancing the field of medical sciences, published by the Pontificia Universidad Javeriana, Facultad de Medicina. Since its transition to an Open Access format in 2010, it has played a pivotal role in promoting the dissemination of high-quality medical research. Featuring a diverse array of studies encompassing clinical practice, public health, and medical education, Universitas Medica aims to provide researchers, healthcare professionals, and students with invaluable insights and the latest findings in medicine. With a focus on enhancing accessibility and fostering collaboration across the medical community, this journal stands out as a critical resource for those looking to stay abreast of innovations and trends. The journal is indexed under ISSN 0041-9095 and E-ISSN 2011-0839 and operates from its base in Bogotá, Colombia, contributing significantly to the scientific landscape both regionally and internationally.

Clinical and Investigative Medicine is a prestigious journal dedicated to advancing the fields of clinical research and medical practice, published by the Canadian Society for Clinical Investigation. With a history of insightful contributions since its inception in 1978, the journal serves as a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and explore critical issues facing contemporary medicine. Housed within the Q3 quartile of the Medicine category, it boasts an impressive Scopus ranking of #280/636, placing it within the 56th percentile amongst its peers. Although it operates on a subscription basis, the journal remains accessible to a broad audience interested in comprehensive reviews, original research, and cutting-edge methodology, ensuring that vital information reaches a global readership. Submit your research to Clinical and Investigative Medicine and contribute to the ongoing dialogue that shapes the future of patient care and medical innovation.

MINERVA MEDICA is a renowned academic journal published by EDIZIONI MINERVA MEDICA, located in Turin, Italy. Established in 1945, it has positioned itself as a significant contributor to the field of medicine, particularly in the miscellaneous medicine category, as evidenced by its Q3 ranking according to the 2023 category quartiles. The journal is indexed under the ISSN 0026-4806 and E-ISSN 1827-1669, ensuring wide accessibility and dissemination of knowledge among medical professionals, researchers, and students alike. With a robust Scopus ranking of #64 out of 636 in General Medicine, placing it in the 90th percentile, MINERVA MEDICA serves as a vital resource for those seeking to stay updated on contemporary medical research and advancements. While not an open-access journal, its commitment to quality and relevance in the medical landscape makes it an essential read for anyone involved in the healthcare sector.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

The Lancet, established in 1823, is one of the most prestigious peer-reviewed journals in the field of medicine, published by Elsevier Science Inc. Renowned for its rigorous standards and commitment to high-quality research, this journal occupies a leading position in the academic world, holding an impressive Q1 category ranking in Medicine (miscellaneous) as of 2023, and ranking #1 out of 636 in the general medicine category with a remarkable 99th percentile according to Scopus. With an emphasis on global health, clinical practice, and medical policy, The Lancet aims to disseminate innovative research that pushes the boundaries of medical knowledge and informs practice worldwide. Although it does not currently offer Open Access options, its high impact factor and historical significance make it an essential resource for researchers, healthcare professionals, and students committed to advancing health and medicine. Engaging with this journal ensures staying at the forefront of critical developments in the medical field.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.

Translational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.

Therapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

Therapeutic Advances in Chronic Disease is a distinguished open-access journal published by SAGE Publications Ltd, with a focus on innovative research and clinical practices addressing chronic diseases—a field increasingly relevant in today's healthcare landscape. Since its inception in 2010, the journal has committed itself to disseminating high-quality research that informs both theory and practice. With an impressive impact factor and ranked Q1 in Medicine (miscellaneous) in 2023, this journal boasts recognition as one of the top-tier publications in the medical community, placing it in the 79th percentile among its peers. Accessible since 2019, it aims to bridge the gap between cutting-edge research and its application in improving patient outcomes, inviting contributions from researchers, clinicians, and health professionals. The journal's comprehensive scope encompasses various aspects of chronic disease management, making it an invaluable resource for those seeking to advance their understanding of this critical field.